Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients

References

• Yonekawa Y Kim IK Pseudophakic cystoid macular edema Curr Opin Ophthalmol 2012 23 1 26 32 22134362
   PubMed Web of Science ®Google Scholar
• Lobo C Pseudophakic cystoid macular edema Ophthalmologica 2012 227 2 61 67 21921587
   PubMed Web of Science ®Google Scholar
• Hayashi K Igarashi C Hirata A Hayashi H Changes in diabetic macular oedema after phacoemulsification surgery Eye (Lond) 2009 23 2 389 396 17962820
   PubMed Web of Science ®Google Scholar
• Horozoglu F Yanyali A Aytug B Nohutcu AF Keskinbora KH Macular thickness changes after phacoemulsification in previously vitrectomized eyes for diabetic macular edema Retina 2011 31 6 1095 1100 21293315
   PubMed Web of Science ®Google Scholar
• Ahmadabadi HF Mohammadi M Beheshtnejad H Mirshahi A Effect of intravitreal triamcinolone acetonide injection on central macular thickness in diabetic patients having phacoemulsification J Cataract Refract Surg 2010 36 6 917 922 20494761
   PubMed Web of Science ®Google Scholar
• Benhamou N Massin P Haouchine B Audren F Tadayoni R Gaudric A Intravitreal triamcinolone for refractory pseudophakic macular edema Am J Ophthalmol 2003 135 2 246 249 12566041
   PubMed Web of Science ®Google Scholar
• Jonas JB Kreissig I Degenring RF Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema Am J Ophthalmol 2003 136 2 384 386 12888077
   PubMed Web of Science ®Google Scholar
• Jonas JB Intravitreal triamcinolone acetonide: a change in a paradigm Ophthalmic Res 2006 38 4 218 245 16763379
   PubMed Web of Science ®Google Scholar
• Zalewski D Raczyńska D Raczyńska K Five-month observation of persistent diabetic macular edema after intravitreal injection of Ozurdex implant Mediators Inflamm 2014 2014 Article ID 364143
   Web of Science ®Google Scholar
• Parravano M Oddone F Boccassini B Exploring the morphological and functional retinal changes after dexamethasone intravitreal implant (Ozurdex®) in macular edema due to retinal vein occlusion Ophthalmic Res 2014 51 3 153 160 24642474
   PubMed Web of Science ®Google Scholar
• Pichi F Specchia C Vitale L Combination therapy with dexamethasone intravitreal implant and macular grid laser in patients with branch retinal vein occlusion Am J Ophthalmol 2014 157 3 607 615. e1 24528934
   PubMed Web of Science ®Google Scholar
• Northern California Retina Vitreous Associates Ozurdex for combined pseudophakic cystoid macular edema and diabetic macular edema after cataract surgery Available from: http://clinicaltrials.gov/ct2/show/NCT01284478. NLM identifier: NCT01284478 Accessed January 6, 2014
   Google Scholar
• Beck RW Moke PS Turpin AH A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol Am J Ophthalmol 2003 135 2 194 205 12566024
   PubMed Web of Science ®Google Scholar
• Adhi M Aziz S Muhammad K Adhi MI Macular thickness by age and gender in healthy eyes using spectral domain optical coherence tomography PLoS One 2012 7 5 e37638 22629435
   PubMed Web of Science ®Google Scholar
• Pollack A Leiba H Bukelman A Oliver M Cystoid macular oedema following cataract extraction in patients with diabetes Br J Ophthalmol 1992 76 4 221 224 1390489
   PubMed Web of Science ®Google Scholar
• Kuppermann BD Blumenkranz MS Haller JA Dexamethasone DDS Phase II Study Group Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema Arch Ophthalmol 2007 125 3 309 317 17353400
   PubMed Web of Science ®Google Scholar
• Williams GA Haller JA Kuppermann BD Dexamethasone DDS Phase II Study Group Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome Am J Ophthalmol 2009 147 6 1048 1054 e1–2 19268890
   PubMed Web of Science ®Google Scholar
• Callanan DG Gupta S Boyer DS Ozurdex PLACID Study Group Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema Ophthalmology 2013 120 9 1843 1851 23706947
   PubMed Web of Science ®Google Scholar
• Haller JA Kuppermann BD Blumenkranz MS Dexamethasone DDS Phase II Study Group Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema Arch Ophthalmol 2010 128 3 289 296 20212197
   PubMed Web of Science ®Google Scholar
• Haller JA Bandello F Belfort RJr Ozurdex GENEVA Study Group Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results Ophthalmology 2011 118 12 2453 2460 21764136
   PubMed Web of Science ®Google Scholar
• Blumenkranz MS Haller JA Kuppermann BD Correlation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edema Retina 2010 30 7 1090 1094 20616686
   PubMed Web of Science ®Google Scholar
• Diabetic Retinopathy Clinical Research Network Browning DJ Glassman AR Aiello LP Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema Ophthalmology 2007 114 3 525 536 17123615
   PubMed Web of Science ®Google Scholar
• Rhee DJ Peck RE Belmont J Intraocular pressure alterations following intravitreal triamcinolone acetonide Br J Ophthalmol 2006 90 8 999 1003 16597664
   PubMed Web of Science ®Google Scholar
• Kocabora MS Yilmazli C Taskapili M Gulkilik G Durmaz S Development of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinolone Clin Ophthalmol 2008 2 1 167 171 19668401
   PubMedGoogle Scholar